Skip to main content

Table 4 Lp-PLA2 activity and LDL by APOE ε4 status

From: Plasma lipoprotein-associated phospholipase A2 activity in Alzheimer's disease, amnestic mild cognitive impairment, and cognitively healthy elderly subjects: a cross-sectional study

   APOE E4+ APOE E4-
Normal control (n = 66) Lp-PLA2, nmol/min/ml (mean, SD) 206.5 (27.0) 194.7 (42.8)
  LDL, mmol/L (mean, SD) 3.1 (1.3) 3.0 (1.1)
aMCI (n = 59) Lp-PLA2, nmol/min/ml (mean, SD) 215.6 (42.1) 195.0 (42.9)
  LDL, mmol/L (mean, SD) 3.1 (0.8) 2.8 (0.8)
AD (n = 78) Lp-PLA2, nmol/min/ml (mean, SD) 207.9 (41.2)* 181.6 (26.0)*
  LDL, mmol/L (mean, SD) 3.1 (1.2)* 2.6 (0.6)*
  1. *P < 0.05 (t-test; values in bold).